R&D Narratives in Annual Reports of European Biopharmaceutical Companies
Keyword(s):
This study has two objectives. Firstly, it explores how do R&D narratives differ in various clusters of biopharmaceutical companies in terms of discussion context and text readability. Secondly, it examines whether the way how biopharmaceutical companies depict their business within R&D context is dependent on R&D expenses or R&D intensity levels. The paper contributes to the literature in applying qualitative and quantitative methods.
2014 ◽
Vol 1025-1026
◽
pp. 641-644
◽
2019 ◽
Vol 7
(4)
◽
pp. 20-27
2019 ◽
pp. 4187-4196